Baxter International Inc (BAX) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Baxter International Inc   (NYSE: BAX)

Baxter International Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BAX Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 32.99 % 47.79 % 65.43 % 46.08 %
Gross Margin (Q1 TTM) 30.11 % 47.83 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 35.35 % 53.99 % 65.55 % 48.95 %
EBITDA Margin (Q1 MRQ) 11 % 18.95 % 18.99 % 20.49 %
EBITDA Margin (Q1 TTM) 6.21 % 18.87 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. 8.67 % 16.65 % 31.38 % 23.41 %
Operating Margin (Q1 MRQ) 2.44 % 12.24 % 16.58 % 16.05 %
Operating Margin (Q1 TTM) -2.65 % 11.25 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. 0.11 % 10.04 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q1 MRQ) -0.22 % 10.53 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q1 TTM) -4.49 % 10.82 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 8.62 % 10.37 % 13.52 %
Net Margin (Q1 MRQ) -0.56 % 7.84 % 8.15 % 11.42 %
Net Margin (Q1 TTM) -9.7 % 7.59 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. - 7.42 % 6.08 % 10.8 %



Business Segment Profit Margin
 
2022
  Explore 2022 Segment  -
2023
  Explore 2023 Segment  -
2024
  Explore 2024 Segment  -
2025
  Explore 2025 Segment  -
United States
  Explore United States Segment  -
International
  Explore International Segment  -
Medical Products Therapies
  Explore Medical Products Therapies Segment  -
Healthcare Systems Technologies
  Explore Healthcare Systems Technologies Segment  -
Pharmaceuticals
  Explore Pharmaceuticals Segment  -
United States Medical Products Therapies
  Explore United States Medical Products Therapies Segment  -
United States Healthcare Systems Technologies
  Explore United States Healthcare Systems Technologies Segment  -
United States Pharmaceuticals
  Explore United States Pharmaceuticals Segment  -
International Medical Products Therapies
  Explore International Medical Products Therapies Segment  -
International Healthcare Systems Technologies
  Explore International Healthcare Systems Technologies Segment  -
International Pharmaceuticals
  Explore International Pharmaceuticals Segment  -
Advanced Surgery Medical Products Therapies
  Explore Advanced Surgery Medical Products Therapies Segment  -
Advanced Surgery United States Medical Products Therapies
  Explore Advanced Surgery United States Medical Products Therapies Segment  -
Advanced Surgery International Medical Products Therapies
  Explore Advanced Surgery International Medical Products Therapies Segment  -
Front Line Care Healthcare Systems Technologies
  Explore Front Line Care Healthcare Systems Technologies Segment  -
Front Line Care United States Healthcare Systems Technologies
  Explore Front Line Care United States Healthcare Systems Technologies Segment  -
Front Line Care International Healthcare Systems Technologies
  Explore Front Line Care International Healthcare Systems Technologies Segment  -
Drug Compounding Pharmaceuticals
  Explore Drug Compounding Pharmaceuticals Segment  -
Drug Compounding International Pharmaceuticals
  Explore Drug Compounding International Pharmaceuticals Segment  -
Other
  Explore Other Segment  -
Other United States
  Explore Other United States Segment  -
Other International
  Explore Other International Segment  -
2026
  Explore 2026 Segment  -
Infusion Therapies Technologies Medical Products Therapies
  Explore Infusion Therapies Technologies Medical Products Therapies Segment  -
Infusion Therapies Technologies United States Medical Products Therapies
  Explore Infusion Therapies Technologies United States Medical Products Therapies Segment  -
Infusion Therapies Technologies International Medical Products Therapies
  Explore Infusion Therapies Technologies International Medical Products Therapies Segment  -
Care Connectivity Solutions Healthcare Systems Technologies
  Explore Care Connectivity Solutions Healthcare Systems Technologies Segment  -
Care Connectivity Solutions United States Healthcare Systems Technologies
  Explore Care Connectivity Solutions United States Healthcare Systems Technologies Segment  -
Care Connectivity Solutions International Healthcare Systems Technologies
  Explore Care Connectivity Solutions International Healthcare Systems Technologies Segment  -
Injectables Anesthesia Pharmaceuticals
  Explore Injectables Anesthesia Pharmaceuticals Segment  -
Injectables Anesthesia United States Pharmaceuticals
  Explore Injectables Anesthesia United States Pharmaceuticals Segment  -
Injectables Anesthesia International Pharmaceuticals
  Explore Injectables Anesthesia International Pharmaceuticals Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) 2.81 % 0.27 % 0.21 % 1.39 %
Free Cash Flow Margin (Q1 TTM) 6.39 % 12.01 % 13.85 % 9.11 %
Free Cash Flow Margin 5 Yr. Avg. - 10.77 % 14.86 % 15.58 %
Net Cash Flow Margin (Q1 MRQ) 1.89 % -0.27 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) -2.45 % -1.02 % 0.13 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 0.81 % 3.16 % 6.44 %
Effective Tax Rate (Q1 MRQ) -183.33 % 21.94 % 25.39 % 18.83 %
Effective Tax Rate (Q1 TTM) -93.11 % 25.71 % 22.93 % 19.44 %
Effective Tax Rate 5 Yr. Avg. - 18.87 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.